FilingReader Intelligence

Alembic Pharmaceuticals schedules Q2 FY26 earnings call for November 4

October 27, 2025 at 06:59 AM UTCBy FilingReader AI

Alembic Pharmaceuticals Limited announced it will host a post results conference call for analysts and institutional investors on Tuesday, November 4, 2025, at 4:00 PM IST. The purpose of the call is to discuss the company's Q2 FY26 unaudited financial results.

The call will feature key management personnel, including Pranav Amin (managing director), Shaunak Amin (managing director), R. K. Baheti (executive director), G Krishnan (cfo), and Ajay Kumar Desai (sr. vp - finance). Participants can register via a Diamond Pass link to receive dial-in details, passcode, and a PIN, or use universal and international toll-free numbers provided in the announcement.

For those connecting through direct dial-in, universal access numbers include +91 22 6280 1411 and +91 22 7115 8312. India national toll free number is 1 800 120 1221. International toll-free options are available for USA (1866 746 2133), UK (080 810 11573), Singapore (800 101 2045), and Hong Kong (800 96 4448). For further information, Ajay Kumar Desai can be reached at +91 22 66953681 or ajay.desai@alembic.co.in.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when ALEMBIC PHARMACEUTICALS publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →